Cytoplasmic Tubular Structures in Liver of HBsAg Carrier Chimpanzees Infected with Delta Agent and Comparison with Cytoplasmic Structures in Non‐A, Non‐B Hepatitis

Tomoteru Kamimura, Antonio Ponzetto, Ferruccio Bonino, Stephen M. Feinstone, John L. Gerin, Robert H. Purcell – 1 January 1983 – Electron microscopic observations were carried out on five HBsAg carrier chimpanzees infected with delta (δ) agent and two chimpanzees infected with human non‐A, non‐B hepatitis. The cytoplasmic tubular structures, which have been recognized in the liver of chimpanzees infected with human non‐A, non‐B hepatitis, were found also in the liver of HBsAg carrier chimpanzees infected with 5 agent.

Cimetidine Kinetics and Dynamics in Patients with Severe Liver Disease

Jean‐Pierre Villeneuve, Hélène Fortunet‐Fouin, Dominique Arsène – 1 January 1983 – Following cimetidine administration, 60% of the dose is excreted as unchanged drug in the urine, and 40% is eliminated by metabolism. We evaluated the effect of liver disease on cimetidine disposition by comparing its kinetics in 7 healthy subjects and 8 patients with alcoholic cirrhosis.

Arteriohepatic Dysplasia. I. Pitfalls in Diagnosis and Management

James Markowitz, Fredric Daum, Ellen I. Kahn, Keith M. Schneider, Henry B. So, R. Peter Altman, Harvey W. Aiges, Garth Alperstein, Mervin Silverberg – 1 January 1983 – Differentiating intrahepatic cholestasis from extrahepatic biliary tract obstruction may be difficult. Four patients with intraoperative cholangiographic evidence of extrahepatic ductal atresia who underwent hepatoportoenterostomy are described. All were ultimately shown to have arteriohepatic dysplasia with hypoplastic but patent extrahepatic ductal systems.

Subscribe to